West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 1,368,400 | 1,266,400 | 1,192,300 | 1,104,700 | 1,055,700 |
| Cost of Goods | 933,700 | 878,700 | 853,000 | 786,600 | 752,100 |
| Gross Profit | 434,700 | 387,700 | 339,300 | 318,100 | 303,600 |
| Operating Expenses | 273,000 | 253,300 | 229,700 | 228,000 | 206,200 |
| Operating Income | 162,400 | 135,100 | 109,600 | 90,700 | 97,500 |
| Interest Expense | 17,000 | 16,700 | 18,200 | 16,800 | 15,200 |
| Other Income | 7,100 | -5,000 | 7,600 | 5,000 | 3,800 |
| Pre-tax Income | 152,500 | 113,400 | 99,000 | 78,900 | 86,100 |
| Income Tax | 40,200 | 32,700 | 23,500 | 13,600 | 13,500 |
| Net Income Continuous | 112,300 | 80,700 | 75,500 | 65,300 | 72,600 |
| Net Income | $112,300 | $80,700 | $75,500 | $65,300 | $72,600 |
| EPS Basic Total Ops | 1.61 | 1.19 | 1.12 | 0.98 | 1.11 |
| EPS Basic Continuous Ops | 1.61 | 1.19 | 1.12 | 0.98 | 1.11 |
| EPS Diluted Total Ops | 1.57 | 1.15 | 1.08 | 0.95 | 1.06 |
| EPS Diluted Continuous Ops | 1.57 | 1.12 | 1.02 | 0.89 | 1.00 |
| EBITDA(a) | $247,600 | $212,000 | $185,300 | $163,900 | $165,600 |